Literature DB >> 15498083

Diurnal blood glucose profiles in women with gestational diabetes with or without hypertension.

A Leinonen1, V Hiilesmaa, H Andersen, K Teramo, R Kaaja.   

Abstract

AIM: The aim of the study was to establish whether diurnal blood glucose profiles differed in women with gestational diabetes (GDM) with different forms of hypertensive complications.
METHODS: The subjects were patients diagnosed at 26-32 gestational weeks as having GDM (n = 178). They were classified as being normotensive, having chronic hypertension (with or without superimposed pre-eclampsia on chronic hypertension) or pregnancy-induced hypertension (with or without proteinuria). We compared diurnal blood glucose profiles (blood glucose taken every 4 h over 24 h) in these three groups.
RESULTS: Hypertension complicated 43% of the women with GDM. The glucose profiles were similar between the three groups, except that in early morning hours (from 04:00 to 08:00 h) blood glucose concentrations increased in mothers with chronic hypertension, whereas they decreased in the normotensive women. In univariate regression analysis, both obesity (BMI > or = 28 kg/m(2)) and chronic hypertension showed significant association with blood glucose rise from 04:00 to 08:00 h, but in a multiple regression model neither showed significant independent effect.
CONCLUSIONS: The rise in blood glucose levels during the early morning hours in women with GDM and chronic hypertension could reflect greater insulin resistance and sympathetic overactivity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15498083     DOI: 10.1111/j.1464-5491.2004.01314.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  4 in total

1.  Evaluation of oral glucose tolerance test, β-cell function and adverse obstetric outcomes.

Authors:  Hongxiu Zhang; Dongmei Zhao; Jie Shen; Xiaoping Zhou; Wenwei Chen; Shiwen Jiang
Journal:  Biomed Rep       Date:  2013-07-16

2.  Oral health in women with pregnancy and delivery complications.

Authors:  J H Meurman; J Furuholm; R Kaaja; H Rintamäki; U Tikkanen
Journal:  Clin Oral Investig       Date:  2006-02-18       Impact factor: 3.573

3.  Ginseng Extracts, GS-KG9 and GS-E3D, Prevent Blood-Brain Barrier Disruption and Thereby Inhibit Apoptotic Cell Death of Hippocampal Neurons in Streptozotocin-Induced Diabetic Rats.

Authors:  Jee Youn Lee; Chan Sol Park; Hae Young Choi; Tae Young Yune
Journal:  Nutrients       Date:  2020-08-09       Impact factor: 5.717

4.  GS-KG9 ameliorates diabetic neuropathic pain induced by streptozotocin in rats.

Authors:  Jee Youn Lee; Hae Young Choi; Chan Sol Park; Mi Kyung Pyo; Tae Young Yune; Go Woon Kim; Sung Hyun Chung
Journal:  J Ginseng Res       Date:  2017-08-16       Impact factor: 6.060

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.